These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

841 related articles for article (PubMed ID: 33511932)

  • 1. Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol.
    Rahul ; Siddique YH
    CNS Neurol Disord Drug Targets; 2021; 20(4):327-342. PubMed ID: 33511932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine.
    Jin S; Zhang L; Wang L
    Biomed Pharmacother; 2023 Sep; 165():115215. PubMed ID: 37494786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavonoid-based therapies in the early management of neurodegenerative diseases.
    Solanki I; Parihar P; Mansuri ML; Parihar MS
    Adv Nutr; 2015 Jan; 6(1):64-72. PubMed ID: 25593144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hesperidin as a Neuroprotective Agent: A Review of Animal and Clinical Evidence.
    Hajialyani M; Hosein Farzaei M; Echeverría J; Nabavi SM; Uriarte E; Sobarzo-Sánchez E
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30759833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases.
    Zhao J; Zhu M; Kumar M; Ngo FY; Li Y; Lao L; Rong J
    CNS Neurol Disord Drug Targets; 2019; 18(2):103-114. PubMed ID: 30394219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavonoids as Potential Therapeutics Against Neurodegenerative Disorders: Unlocking the Prospects.
    Faysal M; Dehbia Z; Zehravi M; Sweilam SH; Haque MA; Kumar KP; Chakole RD; Shelke SP; Sirikonda S; Nafady MH; Khan SL; Nainu F; Ahmad I; Emran TB
    Neurochem Res; 2024 Aug; 49(8):1926-1944. PubMed ID: 38822985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway.
    Frandsen JR; Narayanasamy P
    Redox Biol; 2018 Apr; 14():465-473. PubMed ID: 29080525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin for neurodegenerative diseases: a review.
    Jayawickreme DK; Ekwosi C; Anand A; Andres-Mach M; Wlaź P; Socała K
    Pharmacol Rep; 2024 Aug; 76(4):644-664. PubMed ID: 38904713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of the neuroprotective/neurorescue action of multi-target green tea polyphenols.
    Mandel SA; Weinreb O; Amit T; Youdim MB
    Front Biosci (Schol Ed); 2012 Jan; 4(2):581-98. PubMed ID: 22202078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.
    Khezri MR; Ghasemnejad-Berenji M
    Neurochem Res; 2022 Oct; 47(10):2954-2962. PubMed ID: 35802286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Studies Applied to Flavonoids against Alzheimer's and Parkinson's Diseases.
    Monteiro AFM; Viana JO; Nayarisseri A; Zondegoumba EN; Mendonça Junior FJB; Scotti MT; Scotti L
    Oxid Med Cell Longev; 2018; 2018():7912765. PubMed ID: 30693065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant vs. Prooxidant Properties of the Flavonoid, Kaempferol, in the Presence of Cu(II) Ions: A ROS-Scavenging Activity, Fenton Reaction and DNA Damage Study.
    Simunkova M; Barbierikova Z; Jomova K; Hudecova L; Lauro P; Alwasel SH; Alhazza I; Rhodes CJ; Valko M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New therapeutic strategy for Parkinson's and Alzheimer's disease.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential implications of polyphenolic compounds in neurodegenerative diseases.
    Shi R; Gao D; Stoika R; Liu K; Sik A; Jin M
    Crit Rev Food Sci Nutr; 2024; 64(16):5491-5514. PubMed ID: 36524397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Flavonoids in Neurodegenerative Diseases: Limitations and Future Perspectives.
    Maan G; Sikdar B; Kumar A; Shukla R; Mishra A
    Curr Top Med Chem; 2020; 20(13):1169-1194. PubMed ID: 32297582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases.
    Maher P
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease.
    Braidy N; Behzad S; Habtemariam S; Ahmed T; Daglia M; Nabavi SM; Sobarzo-Sanchez E; Nabavi SF
    CNS Neurol Disord Drug Targets; 2017; 16(4):387-397. PubMed ID: 28474543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
    Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
    Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders.
    Sethiya NK; Ghiloria N; Srivastav A; Bisht D; Chaudhary SK; Walia V; Alam MS
    CNS Neurol Disord Drug Targets; 2024; 23(7):865-882. PubMed ID: 37461364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.